Procaps Gr (NASDAQ:PROC) reported quarterly sales of $110.00 million which missed the analyst consensus estimate of $123.90 million by 11.22 percent.
Why UniQure Stock Is Trading Down Today
UniQure N.V. (NASDAQ: QURE) shares are lower after the company announced interim data from the Phase I/II trial of AMT-130 in Huntington's Disease.